VDAC2 ligands selectively and potently block BAK-mediated apoptosis to allow long-term clonogenic cell survival

ABSTRACT: This study aimed to characterise the protein that a novel compound binds to, thus promoting its ability to inhibit BAK apoptotic activity.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Fibroblast

SUBMITTER: Jarrod Sandow  

LAB HEAD: Andrew Webb

PROVIDER: PXD013129 | Pride | 2019-10-11

REPOSITORIES: Pride